Rich Tyvin
Known title: Chief Medical OfficerCIK: 0001945208
Associated companies
Transaction History
| SHPH | ▼ Sell | Open Market | 1,414 | $2K | 12/29/2022 | View on chart |
| SHPH | ▼ Sell | Open Market | 1,414 | $2K | 12/29/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
SHPH Trades in Motion with Volume Spike and Gap
Shuttle Pharmaceuticals saw a noticeable volume spike and a gap in Thursday’s session, drawing attention from traders. The stock moved above its recent support at $3.42 and is trading near an overbought RSI of 71.2. This activity highlights increased short‑term interest, though the long‑term range remains wide from $2.58 to $55.90.
SHPH Trades in Motion with Volume Spike and Gap. Shuttle Pharmaceuticals saw a noticeable volume spike and a gap in Thursday’s session, drawing attention from traders. The stock moved above its recent support at $3.42 and is trading near an overbought RSI of 71.2. This activity highlights increased short‑term interest, though the long‑term range remains wide from $2.58 to $55.90.